ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$10.38
−5.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 22.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.11x
- Price / sales
- 33.97x
- Price / cash flow
- -11.53x
Enterprise value
- Enterprise value
- $462.3M
- EV / sales
- 23.49x
- EV / EBITDA
- -22.00x
- EV / EBIT
- -20.74x
- Market cap
- $668.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026